Geneva - The Swiss pharmaceutical giant Roch, maker of influenza medication Tamiflu, saw its stock price rise 3.8 per cent in early trading Monday on the Zurich exchange on the back of the global swine flu outbreak. During the avian flu epidemic the drug was used heavily, particularly in South Asia.
Shares in Roche were trading at close to 145 Swiss francs (126 dollars), up over five francs since the opening.
Martina Rupp, a spokeswoman for Roche, said Tamiflu was deemed to be effective against the swine variant.